Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CORT
#745
Corcept Therapeutics Incorporated - Common Stock
121.2
4
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.04%
Monthly Change
+6.93%
6 month change
+191.79%
Year Change
+65.24%
Previous Close
121.1
9
Open
121.2
0
Low
119.2
8
High
122.0
0
Markets
US Stock Market
Healthcare
Biotechnology
CORT
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
117.31 M
105.96 M
107.9 M
103.52 M
105.5 M
106.37 M
108.1 M
Valuation ratios
Enterprise value
2.99 B
2.02 B
2.11 B
2.37 B
5.19 B
3.58 B
12.48 B
Price to earnings ratio
30.78
22.25
23.18
25.7
40.97
42.44
277.39
Price to sales ratio
9.18
6.81
5.82
5.6
8.47
5.48
—
Price to cash flow ratio
21.38
14.86
19.44
21.25
28.87
29.41
129.55
Price to book ratio
6.21
6.64
4.66
5.33
8.41
6.45
5.12
Enterprise value to EBITDA ratio
23.25
16.09
18.6
21.93
37.67
77.95
—
Profitability ratios
Return on assets %
0.19
0.27
0.17
0.17
0.17
0.12
0.05
Return on equity %
0.2
0.3
0.2
0.21
0.21
0.15
0.06
Return on invested capital %
372.2
320.97
276.79
234.22
159.13
69.56
32.72
Gross margin %
98.42
98.56
98.66
98.66
98.39
98.3
98.41
Operating margin %
36.23
34.01
28.03
22.24
20.29
5.88
16.12
EBITDA margin %
36.38
34.31
28.22
22.36
20.41
6.03
16.46
Net margin %
29.96
30.74
25.24
22
20.92
13.09
16.78
Liquidity ratios
Quick ratio
9.97
5.5
6.8
4.31
3.26
2.85
2.77
Current ratio
10.07
5.6
6.89
4.39
3.35
2.92
2.86
Inventory turnover
1.08
1.07
0.97
0.94
1.08
1.01
0.31
Asset turnover
0.72
0.74
0.8
0.8
0.92
0.91
0.3
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.22
1.33
1.04
1.14
1.75
1.18
0.9
EBIT per share
1.03
0.99
0.97
0.96
1.21
0.37
-0
EBITDA per share
1.04
1
0.98
0.97
1.21
0.38
0.01
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.55
1.77
3.72
3.3
3.38
3.1
2.6
Net current asset value per share
3.85
2.12
4.31
4.1
4.16
4.05
3.71
Tangible book value per share
4.21
2.98
4.33
4.53
5.99
5.4
5.96
Working capital per share
3.47
1.74
3.68
3.17
2.92
2.66
2.41
Book value per share
4.21
2.98
4.33
4.53
5.99
5.4
5.96
News
Prime Medicine Stock Rallies Nearly 26% in a Month: Here's Why
PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know
Corcept, IBD Stock Of The Day, Setting Up Amid Booming Earnings Growth
The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike
Is Aspen Pharmacare (APNHY) Stock Outpacing Its Medical Peers This Year?
10 Health Care Stocks With Whale Alerts In Today’s Session
CHMP Backs CORT's Lifyorli Combo in Platinum-Resistant Ovarian Cancer
HC Wainwright & Co. Reiterates Buy on Corcept Therapeutics, Maintains $165 Price Target
Here’s How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 10 Years
Will Korlym Continue to Aid CORT's Growth Through the Rest of 2026?
Corcept Stock: Not Cheap, But Backed By Real Structural Growth (NASDAQ:CORT)